Home
About
∨
Profile
Who We Are
Board of Directors
Services
∨
Overview
Licensing
Technology Sourcing
Technologies
∨
Featured Technologies
Portfolio
News & Press
∨
Current
2021
Investors
∨
CTI at a Glance
Board of Directors
Who We Are
SEC Filings
Corporate Governance
Investor Contacts
Contact
∨
Corporate Offices
Investor Contacts
Latest Press Releases
24 Aug 2016
Calmare Therapeutics Reports Second Quarter 2016 Results
25 May 2016
Calmare Therapeutics to Present at the 5
th
Annual SeeThruEquity Microcap Investor Conference
23 May 2016
Calmare Therapeutics Incorporated Uplists
19 May 2016
Calmare Therapeutics Reports First Quarter 2016 Results
5 May 2016
Calmare Therapeutics Receives Final Signatures on Supply Order Contract Documents
19 Apr 2016
Calmare Therapeutics Reports Year-End 2015 Results
2 Mar 2016
Calmare Therapeutics Reports Third Quarter 2015 Results
18 Feb 2016
Calmare Therapeutics Awarded $15 Million General Supply Order Contract
17 Feb 2016
Calmare Therapeutics Incorporated Appoints Christine Chansky, M.D., J.D., F.C.L.M., Chief Regulatory Officer
Archives
2023
2022
2021
Add the
CTI News & Press
RSS feed to your reader.
Saturday, June 10th 2023
Terms of Service
|
Privacy
|
Legal
|
Sitemap
|
Copyright Calmare Therapeutics Incorporated © 1999-2023